Muscle myopathy and sarcopenia are related to overexpression of myostatin that acts as powerful activator of the Smad2/3 pathway and thereby stimulates the proteasomal and the autophagic-lysosomal capabilities [99–101]. The gene discussed is SMAD2; the disease is sarcopenia.